Actively hiring
Regenerative Medicine
Clinical Research
Biotechnology
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Writing about medicine, biology, stats, and anything in between. Commentary on new medical research, clinical trials, and biotech companies. Click to read Adith Arun, a Substack publication with hundreds of subscribers.
News
Is there really a 400% increase in colorectal cancer incidence amongst children?
The uptick in early-onset ( 50 years old) colorectal cancer incidence has been a topic of much discussion and investigation. One striking observation is that in the US from 1999 to 2020, the incidence rate of colorectal cancers grew 400% in individuals 10
Read more
Report
Trying to understand the Bundibugyo Ebola virus (and profiling what we do NOT know)
Extent of the outbreak and historical contextEstimating case fatality rates and reproductive number of the Ebola virusClinical Course of Ebola Management of EbolaBDBV Clinical CourseBDBV incubation period and precautions2026 BDBV Sequence Similarity to 20
Read more
Report
What do we know about the 2026 Hantavirus outbreak?
An outbreak of hantavirus occurred on the MV Hondius, a cruise ship traveling from Argentina to Cape Verde, in late April/early May. As of May 13, 11 people have been suspected or confirmed to have the Andes Virus (ANDV), a strain of hantavirus capable of
Read more
Report
Should we stop trialing relaxin drugs in pulmonary hypertension?
AstraZeneca's phase 2 Re-PHIRE results in PH-HFAstraZeneca ($AZN) tried a relaxin-mimetic (AZD3427) in patients with pulmonary hypertension associated with heart failure (PH-HF) in the phase 2b Re-PHIRE study. 220 patients were randomized 1:1:1:1 to recei
Read more
Report
Maybe, Maybe not
There is a 2nd century B.C. Chinese story that I enjoy. I first came across a modified version of it and so that's what I will share here.1 It goes: Once upon a time, there was a Chinese farmer who lost a horse. It ran away.All his neighbors came around i
Read more
Report
Pro access
Upgrade to see all 21 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
